P1‐056: Idalopirdine, A 5‐HT6 Antagonist in Phase III Development as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild‐to‐Moderate Alzheimer's Disease: Baseline Data from the Ongoing Starshine Study. (1st July 2016) - Atri, Alireza; Boneva, Neli; Cummings, Jeffrey L.; Frölich, Lutz; Tariot, Pierre N.; Windfeld, Kristian